JPS61227515A - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JPS61227515A
JPS61227515A JP6881185A JP6881185A JPS61227515A JP S61227515 A JPS61227515 A JP S61227515A JP 6881185 A JP6881185 A JP 6881185A JP 6881185 A JP6881185 A JP 6881185A JP S61227515 A JPS61227515 A JP S61227515A
Authority
JP
Japan
Prior art keywords
skin
external preparation
acid
amino acid
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6881185A
Other languages
Japanese (ja)
Inventor
Tomohisa Asahara
智久 浅原
Hidekazu Toyoda
豊田 英一
Shuya Tamaoki
玉置 修哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP6881185A priority Critical patent/JPS61227515A/en
Publication of JPS61227515A publication Critical patent/JPS61227515A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

PURPOSE:An external preparation for the skin preventing change in smell of amino acid with time, providing the skin with proper wetting and tension, and improved beautifying effect, obtained by blending an external preparation for the skin with an amino acid or its derivative and a specific hydroquinone glycoside. CONSTITUTION:An external preparation for the skin such as cosmetic, milky lotion, cream, external preparation for the skin of the body, hair tonic, hair cream, etc., blended with (0.05-10wt%) one or more selected from an amino acid such as glycine, serine, cystine, alanine, aspartic acid, alginine, etc., and an amino acid derivative such as acylsarcosine, acrylglutamic acid, its salts, etc., and (6-20wt%) hydroquinone derivative (preferably hydroquinone beta-D- glycoside) shown by the formula (R is pentose residue, hexose residue, amino acid residue, uronic acid residue or methylated substances thereof).

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は皮膚に適度の「潤い」と「はり」を与える作用
と、皮膚美白作用とを有する皮膚外用剤を提供するもの
である。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention provides an external preparation for skin that has the effect of imparting appropriate "moisturization" and "firmness" to the skin, and the effect of whitening the skin.

[従来技術] 一般に、皮膚角質層の水分が、10〜15%を含んだ状
態がisな皮膚と言われる。水分を含みすぎるとフヤケ
状態となったり、少なすぎるとカサカサした状態となっ
たりするので、これを解決するため、化粧水、クリーム
及び乳液等の皮膚外用剤が使われている。これ等皮膚外
用剤中には保湿剤例えば乳酸ナトリウム、グリセリン、
1.3−ブチレングリコール、プロピレングリコール等
が皮膚に対する親和性、使用感の点から比較的多量(3
〜10%)に用いられる。また、老化や硬化した表皮に
水和性を回復することを期待してアミノ酸が用いられて
いる。
[Prior Art] In general, a state in which the stratum corneum of the skin contains 10 to 15% of water is said to be "is" skin. If the skin contains too much water, it will become flaky, and if it contains too little water, it will become dry. To solve this problem, external skin preparations such as lotions, creams, and emulsions are used. These external skin preparations include moisturizers such as sodium lactate, glycerin,
1.3-Butylene glycol, propylene glycol, etc. are used in relatively large amounts (3-butylene glycol, etc.) from the viewpoint of affinity for the skin and feeling of use.
~10%). Amino acids are also used in the hope of restoring hydration to aging and hardened epidermis.

[発明が解決しようとする問題点] しかしながら、特にリッチ感を訴求する皮膚外用剤にお
いては、上記の保湿剤を極めて多量に配合する傾向にあ
り、そのために皮膚に対するペタツキ感が生じていた。
[Problems to be Solved by the Invention] However, in skin preparations for external use that particularly appeal to a rich feeling, there is a tendency to incorporate extremely large amounts of the above-mentioned humectants, resulting in a sticky feeling on the skin.

また、これら保湿剤配合の皮膚外用剤を低湿度下で使用
すると外気湿度が少なぃことから、皮膚中から保湿剤配
合の皮膚外用剤へと逆に水分がとり込まれ、皮膚を乾燥
甘しウアしまう場合もあった。
In addition, when these external skin preparations containing moisturizers are used in low humidity conditions, the humidity in the outside air is low, so water is drawn from the skin into the external skin preparations containing humectants, leaving the skin dry and dry. There were times when I was disappointed.

一方、アミノ酸を配合した皮膚外用剤は上記保湿剤を配
合した場合のような欠点はないもの。、経時による変臭
が問題となっていた。
On the other hand, external skin preparations containing amino acids do not have the drawbacks of the above-mentioned moisturizers. , odor over time was a problem.

[問題点を解決するための手段] 本発明者等は上記の事情にかんがみ、鋭t?1llF究
ヲ重ねた結果、アミノ酸およびその誘導体よりなる群か
ら選ばれる一種又は二種以上と、特定の7、イドロキノ
ンの配糖体とを配合した皮膚外用剤は、アミノ酸の経時
での変臭がなく、皮膚に適度の「潤い」と「はり」を与
えると共に、しみ、そばかす、色黒などを著しく改善す
るヨ美白効果い優れることを見出し、本発明を完成する
に至った。
[Means for Solving the Problems] In view of the above circumstances, the present inventors have developed the following method. As a result of repeated research into 1llF, we have found that a skin preparation containing one or more selected from the group consisting of amino acids and their derivatives and a specific glycoside of hydroquinone has been found to be effective against deodorization of amino acids over time. The present inventors have discovered that the present invention has an excellent whitening effect that not only provides appropriate "moisture" and "firmness" to the skin, but also significantly improves age spots, freckles, dark skin, etc., leading to the completion of the present invention.

すなわち本発明は、アミノ酸およびその誘導体よりなる
群から選ばれる一種又は二種以上と、下記一般式であら
わされるハイドロキノンの配糖体とを配合することを特
徴とする皮膚外用剤を提供するものである。
That is, the present invention provides an external preparation for skin, characterized in that it contains one or more selected from the group consisting of amino acids and derivatives thereof, and a glycoside of hydroquinone represented by the following general formula. be.

[式中、Rは三次糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。] 以下、本発明の構成について詳述する。
[In the formula, R is a tertiary sugar residue, a hexose sugar residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ] Hereinafter, the structure of the present invention will be explained in detail.

本発明に用いられるアミノ酸とは、グリシン、セリン、
シスチン、アラニン、トレオニン、システィン、バリン
、フェニルアラニン、メチオニン、ロイシン、チロシン
、プロリン、イソロイシン、トリプトファン、ヒドロキ
シプロリン等の中性アミノ酸、アスパラギン酸、アスパ
ラギン、グルタミン、グルタミン酸等の酸性アミノ酸、
アルギニン、ヒスチジン、リジン等の塩基性アミノ酸が
あげられる。
Amino acids used in the present invention include glycine, serine,
Neutral amino acids such as cystine, alanine, threonine, cysteine, valine, phenylalanine, methionine, leucine, tyrosine, proline, isoleucine, tryptophan, and hydroxyproline; acidic amino acids such as aspartic acid, asparagine, glutamine, and glutamic acid;
Examples include basic amino acids such as arginine, histidine, and lysine.

また、アミノ酸誘導体とはアシルサルコシンおよびその
塩、アシルサルコシン酸およびその塩、アシル−β−ア
ラニンおよびその塩、グルタチオン、ピロリドンカルボ
ン酸およびその塩等のほかに、グルタチン、カルノシン
、ゲラムシギンS1チロシジンA1チロシジンB等のオ
リゴペプチドが挙げられる。
Amino acid derivatives include acylsarcosine and its salts, acylsarcosinic acid and its salts, acyl-β-alanine and its salts, glutathione, pyrrolidone carboxylic acid and its salts, as well as glutatine, carnosine, gelamsigin S1 tyrosidine A1 tyrosidine Examples include oligopeptides such as B.

本発明の皮膚外用剤にはこれらのうち、一種又は二種以
上が適宜選択され配合される。
One or more of these may be appropriately selected and blended into the skin external preparation of the present invention.

配合量は、本発明の皮膚外用剤中、0.01−20重量
%、好ましくは、0.05−10重量%である。
The blending amount is 0.01-20% by weight, preferably 0.05-10% by weight in the skin external preparation of the present invention.

配合量が0.01%未満では皮膚に対する保湿効果が弱
く、逆に20%以上加えても効果の増加は実質上望めな
いし、アミノ酸の変臭を防止しにくくなる傾向にある。
If the blending amount is less than 0.01%, the moisturizing effect on the skin will be weak, and on the other hand, if it is added in an amount of 20% or more, no substantial increase in the effect can be expected, and it tends to be difficult to prevent odor from amino acids.

本発明に用いられるハイドロキノンの配糖体は下記一般
式であられきれる。
The hydroquinone glycoside used in the present invention can be represented by the following general formula.

[式中、Rは三次糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。] 式中でRはL−アラビノース、D−アラビノース、D−
キシロース、D−リボース、し−キシロース、L−リキ
ソース、D−リブロース、等の三次糖の残基、D−グル
コース、L−ガラクトース、D−ガラクトース、D−マ
ンノース、D−タロース、D−フルクトース、し−ソル
ボース、D−タガトース、D−プシコースの六炭糖の残
基、D−グルコサミン、D−ガラクトサミン、シアル酸
、アミノウロン酸、ムラミン酸等のアミノ糖の残基、D
−グルクロン酸、D−ガラクツロン酸、D−マンヌロン
酸、L−イズロン酸、し−グルロン酸等のウロン酸の残
基又はそれらのメチル化物を示すが、アミノ酸の変臭防
止効果、保湿効果、入手の仕易ざ、美白効果等がらRが
D−グルコース残基の場合、とくにハイドロキノンにD
−グルコースがβ−結合した、すなわちハイドロキノン
β−リーグルコシド(−船名:アルブチン、以後アルブ
チンという)が好ましい。
[In the formula, R is a tertiary sugar residue, a hexose sugar residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ] In the formula, R is L-arabinose, D-arabinose, D-
Residues of tertiary sugars such as xylose, D-ribose, xylose, L-lyxose, D-ribulose, D-glucose, L-galactose, D-galactose, D-mannose, D-talose, D-fructose, Residues of hexoses such as sorbose, D-tagatose, and D-psicose; residues of amino sugars such as D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, and muramic acid;
- Residues of uronic acids such as glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid, and guluronic acid, or their methylated products; When R is a D-glucose residue, D-
-Glucose is β-linked, ie, hydroquinone β-li glucoside (-ship name: arbutin, hereinafter referred to as arbutin) is preferred.

配合量は、皮膚外用剤全量中の0,1〜30重量%であ
り、好ましくは6〜20重量%である。
The blending amount is 0.1 to 30% by weight, preferably 6 to 20% by weight, based on the total amount of the skin external preparation.

本発明の皮膚外用剤には上記の必須構成成分に加えて、
必要に応じて、通常医薬品、化粧品等の皮膚外用剤に用
いられるその他の成分、例えばエデト酸、二、三又は四
ナトリウム、クエン酸ナトリウム、メタリン酸ナトリウ
ム等の金属イオン封鎖剤、ブチルヒドロキシトルエン(
BHT) 、没食子酸プロピル、トコフェロール等の酸
化防止剤、界面活性剤、紫外線吸収剤、香料、水、エタ
ノール、イソプロパツール等の低級アルコール類、増粘
剤、色剤、粉末、薬剤、クエン酸、リンゴ酸等の有機酸
、リン酸等の無機酸等を配合することができる。当然の
ことながら、これらの成分は本発明の効果を損なわない
質的量的範囲内で用いられなければならない。
In addition to the above-mentioned essential components, the skin external preparation of the present invention includes:
If necessary, other ingredients commonly used in external skin preparations such as pharmaceuticals and cosmetics, such as edetic acid, sequestering agents such as di-, tri-, or tetrasodium, sodium citrate, and sodium metaphosphate, butylated hydroxytoluene (
BHT), antioxidants such as propyl gallate and tocopherol, surfactants, ultraviolet absorbers, fragrances, water, lower alcohols such as ethanol and isopropanol, thickeners, colorants, powders, drugs, citric acid , organic acids such as malic acid, and inorganic acids such as phosphoric acid. Naturally, these components must be used within a qualitative and quantitative range that does not impair the effects of the present invention.

本発明の皮膚外用剤の剤型は任意であり、溶液系、可溶
化系、乳化系、粉末分散系、水−二層系、水−油一粉末
三層系等、どのような剤型でも構わない。
The dosage form of the skin external preparation of the present invention is arbitrary, and any dosage form may be used, such as a solution type, a solubilized type, an emulsion type, a powder dispersion type, a water-two-layer type, a water-oil-one-powder three-layer type, etc. I do not care.

また、本発明の皮膚外用剤の用途も任意であ  ゛す、
化粧水、乳液、クリーム、パック等のフエーシャルおよ
びボディ用皮膚外用剤やヘアトニック、ヘアクリーム、
シャンプー、ヘアリンス等の頭髪皮膚外用剤等にもちい
ることができる。
Furthermore, the use of the skin external preparation of the present invention is arbitrary.
Facial and body skin preparations such as lotions, emulsions, creams, and packs, hair tonics, hair creams,
It can be used in external preparations for hair and skin such as shampoos and hair rinses.

(以下余白) [実施例] つぎに実施例および比較例をあげて、本発明を具体的に
明らかにする。本発明はこれにより限定されるものでは
ない。配合量は重量%である。
(The following is a blank space) [Examples] Next, examples and comparative examples will be given to specifically clarify the present invention. The present invention is not limited thereby. The blending amount is in weight%.

実施例 1    化粧水 次の処方に従い、常法により化粧水を製造した。Example 1 Lotion A lotion was produced by a conventional method according to the following recipe.

エタノール               8.01.
3−ブチレングリコール        5.0ポリオ
キシエチレン(20モル) オレイルアルコールエーテル     1.8アルブチ
ン              0.1ピロリドンカル
ボン酸ナトリウム  −0,5プルラン       
        0.05ホホバ油         
      0.5苛性カリ            
    0.015E D T A−3N a    
          O,01香料         
        0.1イオン交換水        
     残量実施例 2   り リ − ム 次の処方に従い、常法によりクリームを製造した。
Ethanol 8.01.
3-Butylene glycol 5.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.8 Arbutin 0.1 Sodium pyrrolidone carboxylate -0.5 Pullulan
0.05 jojoba oil
0.5 caustic potash
0.015E DT A-3N a
O,01 fragrance
0.1 ion exchange water
Residual Amount Example 2 Cream A cream was produced by a conventional method according to the following recipe.

1.3−ブチレングリコール        3.0ポ
リエチレングリコール4000      1.0グリ
セリン             2.0スクワラン 
             20.0ワセリン    
            5.0セトステアリルアルコ
ール       3.0ポリオキシエチレン(20モ
ル) オレイルアルコールエーテル     1.5グリセリ
ールモノステアレート1.5 アルブチン              20、Oシス
ティン              10.0乳酸ソー
ダ              2.0キサンタンガム
(ケルトロール商品名)O,OSメチJ!パラベン  
          0.1エチルパラベン     
       0.2苛性カリ           
     0.01E D T A−3N a    
          O,01香料         
        0.2イオン交換水        
     残量実施例 3  乳 液 次の処方に従い、常法により乳液を製造した。
1.3-Butylene glycol 3.0 Polyethylene glycol 4000 1.0 Glycerin 2.0 Squalane
20.0 Vaseline
5.0 Cetostearyl alcohol 3.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monostearate 1.5 Arbutin 20, O cysteine 10.0 Sodium lactate 2.0 Xanthan gum (Keltrol brand name) O, OS Mechi J! Paraben
0.1 ethylparaben
0.2 caustic potash
0.01E DT A-3N a
O,01 fragrance
0.2 ion exchange water
Residual Amount Example 3 Emulsion A milky lotion was produced by a conventional method according to the following recipe.

グリセリン             2.0スクワラ
ン              5.0ワセリン   
             1.0セトステアリルアル
コール       0.3ポリオキシエチレン(20
モル) オレイルアルコールエーテル     1.5グリセリ
ールモノオレート1.5 へイドr1キノンーβ−D−アラビノース      
             10.0ポリアクリル酸ナ
トリウム       0.03エチルパラベン   
         0.2アスパラギン酸      
      10.0苛性カリ           
     0゜IE D T A−3N a     
         O,03香料          
       0.2イオン交換水         
    残量実施例4  パ ッ り 次の処方に従い、常法によりパックを製造した。
Glycerin 2.0 Squalane 5.0 Vaseline
1.0 Cetostearyl alcohol 0.3 Polyoxyethylene (20
mole) Oleyl alcohol ether 1.5 Glyceryl monooleate 1.5 Heid r1 quinone-β-D-arabinose
10.0 Sodium polyacrylate 0.03 Ethylparaben
0.2 aspartic acid
10.0 caustic potash
0゜IE D T A-3N a
O,03 fragrance
0.2 ion exchange water
Remaining Amount Example 4 Pack A pack was manufactured by a conventional method according to the following recipe.

ポリエチレングリコール4000      3.0エ
タノール              10.0アルブ
チン              15.0ポリビニル
アルコール         10.0オリーブ油  
            3.0乳酸        
         1・0グルタチオン       
      10,0グルタミン酸         
    10.0カルボキシメチルセルロース    
  0.07メチルバラベン            
0.1エチルパラベン            0.1
苛性カリ                0.02E
DTA−3Na             O,01香
料                 0.1イオン交
換水             残量実施例56 ヘア
クリーム ミツロウ                3.0ワセ
リン               15・0流動パラ
フイン            42.0ポリオキシエ
チレン(5モル) ステアリン酸エステル         3.0ポリオ
キシエチレン(6モル) オレイルアルコールエーテル     2.0ポリオキ
シエチレン(6モル) セチルアルコールエーテル       1.0アルブ
チン              7.0グルタミン酸
             5.0精製水      
         残余香料            
     適量防腐剤               
 適量本発明に係る皮膚外用剤の作用効果を、使用テス
トによりi認した。使用テストは、3o名の女性を各3
群に分はパネルとした。第1群には実施例1の化粧水を
、第2群には実施例2のクリームを、第3群には実施例
3の化粧水を、それぞれ毎日朝と夜の2回、洗顔後適量
を顔面に2週間にわたって塗布させ、肌の潤い、肌のハ
リ、翌朝の肌の潤いの3項目につきその有効性を判定し
た。結果は表1〜表3に示すとおりである。
Polyethylene glycol 4000 3.0 Ethanol 10.0 Arbutin 15.0 Polyvinyl alcohol 10.0 Olive oil
3.0 lactic acid
1.0 glutathione
10,0 glutamic acid
10.0 carboxymethylcellulose
0.07 Methylparaben
0.1 Ethylparaben 0.1
Caustic potash 0.02E
DTA-3Na O,01 Fragrance 0.1 Ion-exchanged water Remaining amount Example 56 Hair cream Beeswax 3.0 Vaseline 15.0 Liquid paraffin 42.0 Polyoxyethylene (5 mol) Stearate ester 3.0 Polyoxyethylene ( 6 moles) Oleyl alcohol ether 2.0 Polyoxyethylene (6 moles) Cetyl alcohol ether 1.0 Arbutin 7.0 Glutamic acid 5.0 Purified water
residual fragrance
Appropriate amount of preservative
The effect of the skin external preparation according to the present invention in an appropriate amount was confirmed through a usage test. In the usage test, 3 o women were each
Groups were divided into panels. The first group was given the lotion of Example 1, the second group was given the cream of Example 2, and the third group was given the lotion of Example 3, twice a day in the morning and at night, in appropriate amounts after washing their face. was applied to the face for two weeks, and its effectiveness was evaluated in three areas: skin moisture, skin firmness, and skin moisture the next morning. The results are shown in Tables 1 to 3.

(以下余白) 表1 表  2 (以下余白) 表  3 表1〜3の結果から明らかなように、本発明の皮膚外用
剤は、肌のうるおい、肌のハリ、翌朝の肌のうるおいに
優れたものであった。さらに、べたつ伊がなく、経時に
おいても変臭が全くなく、美白効果にも優れていた。
(Hereinafter in the margin) Table 1 Table 2 (Hereinafter in the margin) Table 3 As is clear from the results in Tables 1 to 3, the skin external preparation of the present invention was excellent in skin moisture, skin firmness, and next morning skin moisture. It was something. Furthermore, there was no stickiness, there was no odor at all over time, and the skin whitening effect was excellent.

Claims (1)

【特許請求の範囲】 アミノ酸およびその誘導体よりなる群から選ばれる一種
又は二種以上と、下記一般式であらわされるハイドロキ
ノンの配糖体とを配合することを特徴とする皮膚外用剤
。 ▲数式、化学式、表等があります▼ [式中、Rは五炭糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。]
[Scope of Claims] An external preparation for skin, characterized in that it contains one or more selected from the group consisting of amino acids and derivatives thereof, and a glycoside of hydroquinone represented by the following general formula. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, R is a pentose residue, a hexose residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ]
JP6881185A 1985-04-01 1985-04-01 External preparation for skin Pending JPS61227515A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6881185A JPS61227515A (en) 1985-04-01 1985-04-01 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6881185A JPS61227515A (en) 1985-04-01 1985-04-01 External preparation for skin

Publications (1)

Publication Number Publication Date
JPS61227515A true JPS61227515A (en) 1986-10-09

Family

ID=13384465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6881185A Pending JPS61227515A (en) 1985-04-01 1985-04-01 External preparation for skin

Country Status (1)

Country Link
JP (1) JPS61227515A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852949A3 (en) * 1997-03-31 1999-08-04 Shiseido Company Limited Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation
JP2004315384A (en) * 2003-04-14 2004-11-11 Kyowa Hakko Kogyo Co Ltd Bleaching agent
US10751267B2 (en) 2016-12-21 2020-08-25 Conopco, Inc. Personal care compositions comprising poorly soluble compounds
US11077039B2 (en) 2016-12-21 2021-08-03 Conopco, Inc. Topical skin lightening additive and composition with amino acids and nicotinamide compounds
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
US11337908B2 (en) 2016-12-21 2022-05-24 Conopco, Inc. Personal care compositions with cystine
US11540984B2 (en) 2018-05-23 2023-01-03 Conopco, Inc. Nanoemulsions and a method for making the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50155637A (en) * 1974-06-10 1975-12-16
JPS52136925A (en) * 1976-05-12 1977-11-16 Sansho Seiyaku Kk Skin cosmetic
JPS54138130A (en) * 1978-04-14 1979-10-26 Kiguchi Yuugen Cosmetics containing amino acid llcysteine as effective constituent
JPS56154409A (en) * 1980-04-30 1981-11-30 Pola Chem Ind Inc Skin-bleaching cosmetic
JPS59134706A (en) * 1983-01-19 1984-08-02 Kobayashi Kooc:Kk Cosmetic
JPS6016906A (en) * 1983-07-07 1985-01-28 Pola Chem Ind Inc External drug for skin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50155637A (en) * 1974-06-10 1975-12-16
JPS52136925A (en) * 1976-05-12 1977-11-16 Sansho Seiyaku Kk Skin cosmetic
JPS54138130A (en) * 1978-04-14 1979-10-26 Kiguchi Yuugen Cosmetics containing amino acid llcysteine as effective constituent
JPS56154409A (en) * 1980-04-30 1981-11-30 Pola Chem Ind Inc Skin-bleaching cosmetic
JPS59134706A (en) * 1983-01-19 1984-08-02 Kobayashi Kooc:Kk Cosmetic
JPS6016906A (en) * 1983-07-07 1985-01-28 Pola Chem Ind Inc External drug for skin

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852949A3 (en) * 1997-03-31 1999-08-04 Shiseido Company Limited Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation
JP2004315384A (en) * 2003-04-14 2004-11-11 Kyowa Hakko Kogyo Co Ltd Bleaching agent
US10751267B2 (en) 2016-12-21 2020-08-25 Conopco, Inc. Personal care compositions comprising poorly soluble compounds
US10980718B2 (en) 2016-12-21 2021-04-20 Conopco, Inc. Personal care compositions comprising poorly soluble compounds
US11077039B2 (en) 2016-12-21 2021-08-03 Conopco, Inc. Topical skin lightening additive and composition with amino acids and nicotinamide compounds
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
US11337908B2 (en) 2016-12-21 2022-05-24 Conopco, Inc. Personal care compositions with cystine
US11596586B2 (en) 2016-12-21 2023-03-07 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
US11666519B2 (en) 2016-12-21 2023-06-06 Conopco, Inc. Personal care compositions with cystine
US11759412B2 (en) 2016-12-21 2023-09-19 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
US11540984B2 (en) 2018-05-23 2023-01-03 Conopco, Inc. Nanoemulsions and a method for making the same

Similar Documents

Publication Publication Date Title
WO2002083087A1 (en) Sugar intake promoters
JPH0665049A (en) External preparation for skin
JPS61227515A (en) External preparation for skin
JPS61207316A (en) External agent for skin
KR101605324B1 (en) Cosmetic composition for moisturizing skin which alleviates itchiness and dryness by removing keratin and increasing moisture
JPH09268119A (en) Preparation for external use for skin
JPH10167957A (en) Intercellular adhesion suppressing agent
JPH06279231A (en) Cosmetic
JP3004707B2 (en) External preparation for skin
JP2620770B2 (en) External preparation for skin
JP4004426B2 (en) Skin activation external composition
JPH0624934A (en) Cosmetic
JP2003081805A (en) Skin care preparation
JPS61207315A (en) External agent for skin
JPH041115A (en) Dermal drug for external use
JPS61227512A (en) External preparation for skin
JPH06145037A (en) Skin external preparation
JPH09202711A (en) Beautifying and whitening agent and external preparation composition
JPS61227516A (en) External preparation for skin
JP2000063255A (en) Preparation for external use for skin
JP2000327553A (en) Skin preparation for external use
JPH041116A (en) Dermal drug for external use
KR102084521B1 (en) Compositions for prevention and improvement of acne
JPH08268870A (en) Dermal preparation for external use
JPH09241295A (en) Skin preparation for external use